Clinical Trial Update: Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating dose-dense chemotherapy with Rituximab, with or without intensified high-dose chemoimmunotherapy, supported by peripheral auto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Diffuse Large B-Cell Lymphoma, IPI≥2 | Phase 3 | Status: UNKNOWN